| __timestamp | Axsome Therapeutics, Inc. | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1392830 | 9335772 |
| Thursday, January 1, 2015 | 2419289 | 12390000 |
| Friday, January 1, 2016 | 6343648 | 25602000 |
| Sunday, January 1, 2017 | 7206691 | 21262000 |
| Monday, January 1, 2018 | 9351522 | 28430000 |
| Tuesday, January 1, 2019 | 13598030 | 40849000 |
| Wednesday, January 1, 2020 | 28896749 | 60210000 |
| Friday, January 1, 2021 | 66646205 | 83664000 |
| Saturday, January 1, 2022 | 159253661 | 104097000 |
| Sunday, January 1, 2023 | 323123000 | 106916000 |
| Monday, January 1, 2024 | 411359000 |
Data in motion
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Axsome Therapeutics, Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, Axsome's SG&A expenses skyrocketed by over 23,000%, reflecting its aggressive growth strategy. In contrast, Iovance's expenses increased by approximately 1,045%, indicating a more measured approach.
This trend highlights Axsome's rapid expansion and investment in its operational infrastructure, while Iovance's steady increase suggests a focus on sustainable growth.
AbbVie Inc. vs Axsome Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Sanofi and Axsome Therapeutics, Inc.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Neurocrine Biosciences, Inc. vs Axsome Therapeutics, Inc.
Neurocrine Biosciences, Inc. and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
BioMarin Pharmaceutical Inc. and Iovance Biotherapeutics, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Amneal Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. and HUTCHMED (China) Limited: SG&A Spending Patterns Compared
CymaBay Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Manages SG&A Costs Better?